nodes	percent_of_prediction	percent_of_DWPC	metapath
Alpha-Linolenic Acid—Azelaic Acid—SRD5A2—uterine cancer	0.0396	1	CrCbGaD
Alpha-Linolenic Acid—Haemorrhagic disorder—Medroxyprogesterone Acetate—uterine cancer	0.0376	0.209	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—myometrium—uterine cancer	0.0331	0.0535	CbGeAlD
Alpha-Linolenic Acid—FABP3—renal system—uterine cancer	0.0271	0.0437	CbGeAlD
Alpha-Linolenic Acid—SLC8A1—smooth muscle tissue—uterine cancer	0.0251	0.0405	CbGeAlD
Alpha-Linolenic Acid—SLC8A1—renal system—uterine cancer	0.0241	0.039	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—endometrium—uterine cancer	0.0233	0.0377	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—mammalian vulva—uterine cancer	0.0226	0.0364	CbGeAlD
Alpha-Linolenic Acid—FADS2—epithelium—uterine cancer	0.0221	0.0357	CbGeAlD
Alpha-Linolenic Acid—FADS1—myometrium—uterine cancer	0.0221	0.0357	CbGeAlD
Alpha-Linolenic Acid—FADS2—uterine cervix—uterine cancer	0.0219	0.0354	CbGeAlD
Alpha-Linolenic Acid—FABP3—female reproductive system—uterine cancer	0.0217	0.035	CbGeAlD
Alpha-Linolenic Acid—FADS2—smooth muscle tissue—uterine cancer	0.0213	0.0344	CbGeAlD
Alpha-Linolenic Acid—FADS2—decidua—uterine cancer	0.0209	0.0337	CbGeAlD
Alpha-Linolenic Acid—FADS2—renal system—uterine cancer	0.0205	0.0331	CbGeAlD
Alpha-Linolenic Acid—SLC8A1—female reproductive system—uterine cancer	0.0193	0.0312	CbGeAlD
Alpha-Linolenic Acid—FADS2—mammalian vulva—uterine cancer	0.0192	0.031	CbGeAlD
Alpha-Linolenic Acid—FADS2—uterus—uterine cancer	0.0183	0.0295	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—vagina—uterine cancer	0.0175	0.0282	CbGeAlD
Alpha-Linolenic Acid—TRPV1—epithelium—uterine cancer	0.0173	0.028	CbGeAlD
Alpha-Linolenic Acid—FADS1—uterine cervix—uterine cancer	0.0172	0.0278	CbGeAlD
Alpha-Linolenic Acid—FADS1—smooth muscle tissue—uterine cancer	0.0167	0.027	CbGeAlD
Alpha-Linolenic Acid—FADS2—female reproductive system—uterine cancer	0.0164	0.0265	CbGeAlD
Alpha-Linolenic Acid—FADS1—decidua—uterine cancer	0.0164	0.0265	CbGeAlD
Alpha-Linolenic Acid—TRPV1—renal system—uterine cancer	0.0161	0.026	CbGeAlD
Alpha-Linolenic Acid—FADS1—endometrium—uterine cancer	0.0156	0.0251	CbGeAlD
Alpha-Linolenic Acid—FADS1—mammalian vulva—uterine cancer	0.015	0.0243	CbGeAlD
Alpha-Linolenic Acid—FADS2—female gonad—uterine cancer	0.0149	0.0241	CbGeAlD
Alpha-Linolenic Acid—FADS1—uterus—uterine cancer	0.0143	0.0232	CbGeAlD
Alpha-Linolenic Acid—FABP7—female reproductive system—uterine cancer	0.0142	0.0229	CbGeAlD
Alpha-Linolenic Acid—TRPV1—female reproductive system—uterine cancer	0.0129	0.0208	CbGeAlD
Alpha-Linolenic Acid—FADS1—female gonad—uterine cancer	0.0117	0.0189	CbGeAlD
Alpha-Linolenic Acid—FADS1—vagina—uterine cancer	0.0117	0.0188	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—lymph node—uterine cancer	0.0113	0.0183	CbGeAlD
Alpha-Linolenic Acid—Eructation—Progesterone—uterine cancer	0.0103	0.0573	CcSEcCtD
Alpha-Linolenic Acid—FADS2—lymph node—uterine cancer	0.00961	0.0155	CbGeAlD
Alpha-Linolenic Acid—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—YWHAE—uterine cancer	0.00895	0.0553	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—lymph node—uterine cancer	0.00754	0.0122	CbGeAlD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Progesterone—uterine cancer	0.00685	0.0381	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Progesterone—uterine cancer	0.00671	0.0374	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Medroxyprogesterone Acetate—uterine cancer	0.00608	0.0338	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—Myometrial Relaxation and Contraction Pathways—CALD1—uterine cancer	0.00549	0.0339	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.0053	0.0328	CbGpPWpGaD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.00484	0.027	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Progesterone—uterine cancer	0.00458	0.0255	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00424	0.0262	CbGpPWpGaD
Alpha-Linolenic Acid—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00415	0.0231	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00407	0.0226	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00383	0.0237	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00383	0.0237	CbGpPWpGaD
Alpha-Linolenic Acid—Anaphylactic shock—Progesterone—uterine cancer	0.00374	0.0208	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Etoposide—uterine cancer	0.00343	0.0191	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00339	0.0189	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Progesterone—uterine cancer	0.00329	0.0183	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Ectoderm Differentiation—FGFR2—uterine cancer	0.00327	0.0202	CbGpPWpGaD
Alpha-Linolenic Acid—Gastrointestinal disorder—Progesterone—uterine cancer	0.00323	0.018	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00321	0.0199	CbGpPWpGaD
Alpha-Linolenic Acid—Constipation—Progesterone—uterine cancer	0.0032	0.0178	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00307	0.0189	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00307	0.0189	CbGpPWpGaD
Alpha-Linolenic Acid—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00298	0.0166	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—Calcium Regulation in the Cardiac Cell—YWHAE—uterine cancer	0.00298	0.0184	CbGpPWpGaD
Alpha-Linolenic Acid—Eructation—Epirubicin—uterine cancer	0.00295	0.0164	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—Trk receptor signaling mediated by the MAPK pathway—NRAS—uterine cancer	0.00293	0.0181	CbGpPWpGaD
Alpha-Linolenic Acid—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00293	0.0163	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.0029	0.0161	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—Myometrial Relaxation and Contraction Pathways—YWHAE—uterine cancer	0.00288	0.0178	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00281	0.0174	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—NRAS—uterine cancer	0.0028	0.0173	CbGpPWpGaD
Alpha-Linolenic Acid—Eructation—Doxorubicin—uterine cancer	0.00273	0.0152	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Progesterone—uterine cancer	0.00265	0.0147	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—Trk receptor signaling mediated by the MAPK pathway—KRAS—uterine cancer	0.00252	0.0156	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Ectoderm Differentiation—CCL2—uterine cancer	0.00246	0.0152	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—KRAS—uterine cancer	0.00241	0.0149	CbGpPWpGaD
Alpha-Linolenic Acid—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.0024	0.0133	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Progesterone—uterine cancer	0.00238	0.0132	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism—SRD5A2—uterine cancer	0.00236	0.0146	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NDUFB11—uterine cancer	0.00236	0.0146	CbGpPWpGaD
Alpha-Linolenic Acid—Rash—Progesterone—uterine cancer	0.00236	0.0131	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Progesterone—uterine cancer	0.00236	0.0131	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00232	0.0144	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00232	0.0144	CbGpPWpGaD
Alpha-Linolenic Acid—Dysgeusia—Etoposide—uterine cancer	0.0023	0.0128	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.00229	0.0142	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00225	0.0139	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—PIK3CA—uterine cancer	0.00221	0.0137	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.00217	0.0134	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00216	0.012	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—Trk receptor signaling mediated by the MAPK pathway—HRAS—uterine cancer	0.00214	0.0132	CbGpPWpGaD
Alpha-Linolenic Acid—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00214	0.0119	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00214	0.0119	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—uterine cancer	0.00205	0.0127	CbGpPWpGaD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00197	0.0109	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.00192	0.0107	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Etoposide—uterine cancer	0.00191	0.0106	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NDUFB11—uterine cancer	0.00189	0.0117	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—SRD5A2—uterine cancer	0.00189	0.0117	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—uterine cancer	0.00187	0.0116	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00184	0.0114	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.00183	0.0113	CbGpPWpGaD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00182	0.0101	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—AKT1—uterine cancer	0.00181	0.0112	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Ectoderm Differentiation—CTNNB1—uterine cancer	0.0018	0.0111	CbGpPWpGaD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00178	0.00991	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00178	0.011	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.00173	0.0107	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—STAR—uterine cancer	0.00171	0.0106	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—AKR1B1—uterine cancer	0.00171	0.0106	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00171	0.0105	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.00169	0.0104	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Dactinomycin—uterine cancer	0.00168	0.00935	CcSEcCtD
Alpha-Linolenic Acid—Rash—Dactinomycin—uterine cancer	0.00167	0.00928	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Etoposide—uterine cancer	0.00165	0.00919	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Etoposide—uterine cancer	0.00164	0.00911	CcSEcCtD
Alpha-Linolenic Acid—FADS1—PPARA activates gene expression—EP300—uterine cancer	0.00152	0.00938	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.00149	0.00918	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SRD5A2—uterine cancer	0.00143	0.00885	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NDUFB11—uterine cancer	0.00143	0.00885	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.00139	0.00859	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—STAR—uterine cancer	0.00137	0.00844	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—AKR1B1—uterine cancer	0.00137	0.00844	CbGpPWpGaD
Alpha-Linolenic Acid—Pruritus—Etoposide—uterine cancer	0.00135	0.00753	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.00135	0.00835	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.00135	0.00834	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—POLD1—uterine cancer	0.00134	0.00828	CbGpPWpGaD
Alpha-Linolenic Acid—Malnutrition—Epirubicin—uterine cancer	0.00131	0.00731	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.00131	0.00811	CbGpPWpGaD
Alpha-Linolenic Acid—Dysgeusia—Epirubicin—uterine cancer	0.00129	0.00716	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism—AKR1C1—uterine cancer	0.00125	0.00775	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Etoposide—uterine cancer	0.00122	0.00677	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Doxorubicin—uterine cancer	0.00122	0.00677	CcSEcCtD
Alpha-Linolenic Acid—Rash—Etoposide—uterine cancer	0.00121	0.00671	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Etoposide—uterine cancer	0.00121	0.00671	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—IRF1—uterine cancer	0.0012	0.0074	CbGpPWpGaD
Alpha-Linolenic Acid—Dysgeusia—Doxorubicin—uterine cancer	0.00119	0.00663	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism—RRM2—uterine cancer	0.00112	0.00691	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—DCN—uterine cancer	0.00108	0.0067	CbGpPWpGaD
Alpha-Linolenic Acid—Anaphylactic shock—Epirubicin—uterine cancer	0.00107	0.00597	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism—POLD1—uterine cancer	0.00107	0.00662	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—STAR—uterine cancer	0.00103	0.0064	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—AKR1B1—uterine cancer	0.00103	0.0064	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.00102	0.00633	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.00102	0.00632	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP11A1—uterine cancer	0.00102	0.00632	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—AKR1C1—uterine cancer	0.001	0.00619	CbGpPWpGaD
Alpha-Linolenic Acid—Anaphylactic shock—Doxorubicin—uterine cancer	0.000993	0.00552	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism—AKR1C3—uterine cancer	0.000965	0.00596	CbGpPWpGaD
Alpha-Linolenic Acid—Dyspepsia—Epirubicin—uterine cancer	0.000944	0.00525	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000926	0.00515	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Epirubicin—uterine cancer	0.000917	0.0051	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism—RRM2—uterine cancer	0.000893	0.00552	CbGpPWpGaD
Alpha-Linolenic Acid—Dyspepsia—Doxorubicin—uterine cancer	0.000874	0.00486	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism—DCN—uterine cancer	0.000867	0.00536	CbGpPWpGaD
Alpha-Linolenic Acid—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000857	0.00477	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Doxorubicin—uterine cancer	0.000849	0.00472	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP11A1—uterine cancer	0.000817	0.00505	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—POLD1—uterine cancer	0.000812	0.00502	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—AKR1C3—uterine cancer	0.000771	0.00477	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—AKR1C1—uterine cancer	0.000759	0.00469	CbGpPWpGaD
Alpha-Linolenic Acid—Pruritus—Epirubicin—uterine cancer	0.000759	0.00422	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP19A1—uterine cancer	0.000752	0.00465	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—STK11—uterine cancer	0.000752	0.00465	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000706	0.00436	CbGpPWpGaD
Alpha-Linolenic Acid—Pruritus—Doxorubicin—uterine cancer	0.000702	0.00391	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Epirubicin—uterine cancer	0.000682	0.0038	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—RRM2—uterine cancer	0.000677	0.00418	CbGpPWpGaD
Alpha-Linolenic Acid—Rash—Epirubicin—uterine cancer	0.000676	0.00376	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Epirubicin—uterine cancer	0.000676	0.00376	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000673	0.00416	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—DCN—uterine cancer	0.000657	0.00406	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Doxorubicin—uterine cancer	0.000631	0.00351	CcSEcCtD
Alpha-Linolenic Acid—Rash—Doxorubicin—uterine cancer	0.000626	0.00348	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Doxorubicin—uterine cancer	0.000625	0.00348	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP11A1—uterine cancer	0.000619	0.00383	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—STK11—uterine cancer	0.000601	0.00371	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP19A1—uterine cancer	0.000601	0.00371	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—AKR1C3—uterine cancer	0.000585	0.00361	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—MTHFR—uterine cancer	0.000565	0.00349	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000564	0.00349	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000538	0.00333	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000498	0.00308	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP19A1—uterine cancer	0.000455	0.00282	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—STK11—uterine cancer	0.000455	0.00282	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—MTHFR—uterine cancer	0.000452	0.00279	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000428	0.00264	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000408	0.00252	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000398	0.00246	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—EP300—uterine cancer	0.000374	0.00231	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—VEGFA—uterine cancer	0.000354	0.00219	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—NRAS—uterine cancer	0.00035	0.00216	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—MTHFR—uterine cancer	0.000342	0.00212	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PTEN—uterine cancer	0.000314	0.00194	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000302	0.00186	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—KRAS—uterine cancer	0.000301	0.00186	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—EP300—uterine cancer	0.0003	0.00185	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PIK3CA—uterine cancer	0.000277	0.00171	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—TP53—uterine cancer	0.000267	0.00165	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—HRAS—uterine cancer	0.000256	0.00158	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PTEN—uterine cancer	0.000251	0.00155	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—EP300—uterine cancer	0.00024	0.00148	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—AKT1—uterine cancer	0.000226	0.0014	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PIK3CA—uterine cancer	0.000222	0.00137	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PTEN—uterine cancer	0.00019	0.00118	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—EP300—uterine cancer	0.000182	0.00112	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—AKT1—uterine cancer	0.000181	0.00112	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PIK3CA—uterine cancer	0.000177	0.0011	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—AKT1—uterine cancer	0.000145	0.000895	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PIK3CA—uterine cancer	0.000134	0.00083	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—AKT1—uterine cancer	0.00011	0.000678	CbGpPWpGaD
